Dachaigh › Cancer Pancreatic › Minnesota › Rochester
Sgrùdaidhean clionaigeach Cancer Pancreatic ann an Rochester, MN
Tha 22 sgrùdaidhean airson Cancer Pancreatic a’ lorg phàirtichean aig làraichean ann agus timcheall air Rochester (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
A’ fastadhÌre 2
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
A’ fastadhÌre 1
- Mayo Clinic Rochester, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
A’ fastadhSgrùdadh amharc
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A’ fastadhÌre 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A’ fastadhÌre 3
- Mayo Clinic Cancer Center, Rochester
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A’ fastadhÌre 1/2
- Mayo Clinic, Rochester
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
A’ fastadhSgrùdadh amharc
- Mayo Clinic in Rochester, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
A’ fastadhÌre 2
- Mayo Clinic Rochester, Rochester
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
A’ fastadhÌre 2
- Local Institution - 0129, Rochester
- Local Institution - 0174, Rochester
- Local Institution - 0181, Rochester
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
A’ fastadhÌre 2
- Mayo Clinic in Rochester, Rochester
CREO - Microwave Ablation Feasibility Study
A’ fastadh
- Mayo Clinic Rochester, Rochester
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
A’ fastadhSgrùdadh amharc
- Mayo Clinic in Rochester, Rochester
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
A’ fastadhÌre 2
- Mayo Clinical Rochester, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
A’ fastadhÌre 1
- Mayo Clinic, Rochester
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
A’ fastadhÌre 2
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A’ fastadhÌre 1/2
- Mayo Clinic Rochester, Rochester
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Mayo Clinic in Rochester, Rochester
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
A’ fastadhSgrùdadh amharc
- Mayo Clinic in Rochester, Rochester
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A’ fastadhÌre 2
- Ohio State University Telemedicine, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Mayo Clinic, Rochester
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
A’ fastadhÌre 1/2
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #14, Rochester
Sgrùdaidhean Cancer Pancreatic ann am bailtean eile
- Houston, TX61 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Boston, MA43 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- Los Angeles, CA35 sgrùdaidhean
- St. Louis, MO33 sgrùdaidhean
- Arlington, VA33 sgrùdaidhean
- Baltimore, MD31 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Tampa, FL26 sgrùdaidhean
- Durham, NC24 sgrùdaidhean
Sgrùdaidhean eile ann an Rochester
- Aillse a' bhroilleach42 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag37 sgrùdaidhean
- Ailse metastatach31 sgrùdaidhean
- Aillse (gach seòrsa)30 sgrùdaidhean
- Cancer Ovarian29 sgrùdaidhean
- Aillse colorectal29 sgrùdaidhean
- Myeloma iomaill24 sgrùdaidhean
- Fàilligeadh a' Chridhe22 sgrùdaidhean
- Aillse Prostata22 sgrùdaidhean
- Ailse Endometrial20 sgrùdaidhean
- Ailseachadh nan Sgamhan20 sgrùdaidhean
- Leukemia Lymphocytic Cronach18 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.